PolarCool Past Earnings Performance
Past criteria checks 0/6
PolarCool's earnings have been declining at an average annual rate of -16.7%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 37% per year.
Key information
-16.7%
Earnings growth rate
34.6%
EPS growth rate
Medical Equipment Industry Growth | 6.2% |
Revenue growth rate | 37.0% |
Return on equity | n/a |
Net Margin | -655.1% |
Next Earnings Update | 29 Nov 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How PolarCool makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 2 | -11 | 9 | 0 |
31 Mar 24 | 1 | -11 | 10 | 0 |
31 Dec 23 | 1 | -12 | 11 | 0 |
30 Sep 23 | 2 | -13 | 12 | 0 |
30 Jun 23 | 2 | -12 | 12 | 0 |
31 Mar 23 | 2 | -13 | 12 | 0 |
31 Dec 22 | 2 | -12 | 12 | 0 |
30 Sep 22 | 2 | -11 | 11 | 0 |
30 Jun 22 | 1 | -11 | 11 | 0 |
31 Mar 22 | 1 | -8 | 9 | 0 |
31 Dec 21 | 1 | -7 | 8 | 0 |
30 Sep 21 | 1 | -8 | 8 | 0 |
30 Jun 21 | 1 | -7 | 8 | 0 |
31 Mar 21 | 1 | -7 | 8 | 0 |
31 Dec 20 | 1 | -7 | 8 | 0 |
30 Sep 20 | 1 | -7 | 9 | 0 |
30 Jun 20 | 1 | -7 | 9 | 0 |
31 Mar 20 | 0 | -7 | 9 | 0 |
31 Dec 19 | 0 | -7 | 8 | 0 |
30 Sep 19 | 0 | -5 | 6 | 0 |
30 Jun 19 | 0 | -5 | 5 | 0 |
31 Mar 19 | 0 | -3 | 3 | 0 |
31 Dec 18 | 0 | -2 | 2 | 0 |
Quality Earnings: POLAR is currently unprofitable.
Growing Profit Margin: POLAR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: POLAR is unprofitable, and losses have increased over the past 5 years at a rate of 16.7% per year.
Accelerating Growth: Unable to compare POLAR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: POLAR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).
Return on Equity
High ROE: POLAR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.